| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.729 | 0.011 | 0.729 | Analgesic | |||
| 0.625 | 0.018 | 0.786 | Antiobesity | 0.786 0.006 CID_131770057 | CID_131770057 | |
| 0.623 | 0.024 | 0.623 | Cyclophilin D inhibitor | 0.483 0.055 CID_131770057 | ||
| 0.521 | 0.024 | 0.521 | 5 Hydroxytryptamine release stimulant | 0.215 0.11 CID_131770057 | ||
| 0.472 | 0.1 | 0.472 | Antiinflammatory | |||
| 0.35 | 0.038 | 0.35 | Tumour necrosis factor alpha release inhibitor | |||
| 0.266 | 0.01 | 0.266 | 5 Hydroxytryptamine agonist | |||
| 0.256 | 0.004 | 0.256 | 5 Hydroxytryptamine 2C agonist | 0.087 0.009 CID_131770057 | ||
| 0.288 | 0.041 | 0.288 | Sigma receptor agonist | |||
| 0.239 | 0.005 | 0.239 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.228 | 0.008 | 0.228 | Opioid kappa receptor antagonist | |||
| 0.243 | 0.027 | 0.243 | Acetylcholine M1 receptor antagonist | |||
| 0.235 | 0.048 | 0.235 | Neurotrophic factor enhancer | 0.149 0.139 CID_131770057 | ||
| 0.248 | 0.07 | 0.248 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.317 | 0.143 | 0.317 | Calcium channel L-type activator | |||
| 0.267 | 0.094 | 0.267 | Nootropic | |||
| 0.243 | 0.082 | 0.243 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.198 | 0.042 | 0.198 | Protein kinase stimulant | 0.177 0.051 CID_131770057 | ||
| 0.17 | 0.02 | 0.17 | TRPA1 agonist | 0.115 0.064 CID_131770057 | ||
| 0.163 | 0.014 | 0.163 | NMDA 2 receptor antagonist | |||
| 0.167 | 0.02 | 0.167 | NMDA receptor antagonist | |||
| 0.188 | 0.048 | 0.256 | ATPase inhibitor | 0.256 0.012 CID_131770057 | CID_131770057 | |
| 0.161 | 0.023 | 0.161 | Opioid antagonist | |||
| 0.234 | 0.098 | 0.234 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.19 | 0.056 | 0.19 | Antipruritic | |||
| 0.146 | 0.013 | 0.146 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.26 | 0.135 | 0.26 | Calcium channel activator | |||
| 0.204 | 0.078 | 0.204 | Psychostimulant | |||
| 0.126 | 0.003 | 0.126 | Purinergic P2Y2 antagonist | |||
| 0.197 | 0.076 | 0.197 | Anesthetic general | |||
| 0.159 | 0.038 | 0.159 | Pregnane X receptor agonist | |||
| 0.14 | 0.019 | 0.14 | Opioid mu receptor antagonist | |||
| 0.135 | 0.017 | 0.135 | Dopamine D1 antagonist | |||
| 0.157 | 0.04 | 0.157 | Acetylcholine muscarinic antagonist | |||
| 0.135 | 0.022 | 0.135 | Opioid delta receptor antagonist | |||
| 0.288 | 0.179 | 0.288 | 5 Hydroxytryptamine release inhibitor | 0.249 0.229 CID_131770057 | ||
| 0.121 | 0.018 | 0.121 | Glycine receptor antagonist | 0.088 0.046 CID_131770057 | ||
| 0.208 | 0.105 | 0.208 | Neuropeptide Y2 antagonist | |||
| 0.166 | 0.069 | 0.166 | Arachidonic acid antagonist | |||
| 0.104 | 0.013 | 0.104 | 5 Hydroxytryptamine 2A agonist | |||
| 0.1 | 0.009 | 0.1 | 5 Hydroxytryptamine 2 agonist | |||
| 0.195 | 0.107 | 0.195 | RNA-directed DNA polymerase inhibitor | |||
| 0.149 | 0.062 | 0.149 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.23 | 0.144 | 0.23 | Vasodilator, peripheral | |||
| 0.136 | 0.053 | 0.136 | Cholesterol synthesis inhibitor | 0.103 0.084 CID_131770057 | ||
| 0.166 | 0.084 | 0.166 | Amyloid beta precursor protein antagonist | 0.163 0.087 CID_131770057 | ||
| 0.14 | 0.058 | 0.14 | Cholinergic antagonist | |||
| 0.116 | 0.035 | 0.116 | Glutamate (mGluR7) agonist | |||
| 0.085 | 0.005 | 0.085 | 5 Hydroxytryptamine 2B agonist | |||
| 0.089 | 0.01 | 0.089 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.136 | 0.058 | 0.136 | Acetylcholine antagonist | |||
| 0.086 | 0.01 | 0.086 | Calcium channel P-type blocker | |||
| 0.089 | 0.014 | 0.089 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.081 | 0.007 | 0.081 | Cholesterol esterase inhibitor | |||
| 0.141 | 0.069 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.069 CID_131770057 | ||
| 0.148 | 0.076 | 0.148 | Insulin secretagoues | |||
| 0.121 | 0.052 | 0.121 | GABA C receptor antagonist | |||
| 0.236 | 0.168 | 0.236 | GABA C receptor rho-3 antagonist | |||
| 0.086 | 0.019 | 0.086 | NMDA 2B receptor antagonist | |||
| 0.092 | 0.025 | 0.092 | Purinergic P2 antagonist | |||
| 0.091 | 0.027 | 0.091 | Glycine receptor agonist | 0.077 0.042 CID_131770057 | ||
| 0.129 | 0.067 | 0.129 | Vanilloid 1 agonist | |||
| 0.08 | 0.025 | 0.08 | NMDA 2C receptor antagonist | |||
| 0.186 | 0.132 | 0.186 | Spasmolytic | |||
| 0.092 | 0.039 | 0.092 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.173 | 0.121 | 0.173 | Aldehyde oxidase inhibitor | |||
| 0.097 | 0.047 | 0.097 | Acetylcholine M3 receptor agonist | |||
| 0.096 | 0.048 | 0.096 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.059 | 0.013 | 0.059 | Guanylate cyclase inhibitor | 0.042 0.03 CID_131770057 | ||
| 0.072 | 0.029 | 0.072 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.133 | 0.091 | 0.133 | Thiol protease inhibitor | |||
| 0.071 | 0.03 | 0.071 | Acetylcholine M5 receptor antagonist | |||
| 0.047 | 0.009 | 0.047 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.021 CID_131770057 | ||
| 0.082 | 0.045 | 0.082 | Acetylcholine M4 receptor antagonist | |||
| 0.044 | 0.007 | 0.044 | LFA antagonist | |||
| 0.066 | 0.03 | 0.066 | Acetylcholine muscarinic agonist | |||
| 0.086 | 0.05 | 0.086 | Neuropeptide Y antagonist | |||
| 0.076 | 0.04 | 0.076 | Dopamine agonist | |||
| 0.115 | 0.08 | 0.115 | Glutamate receptor antagonist | |||
| 0.06 | 0.027 | 0.06 | Dopamine D4 agonist | |||
| 0.06 | 0.028 | 0.06 | Autotaxin inhibitor | |||
| 0.061 | 0.029 | 0.061 | Pregnane X receptor antagonist | |||
| 0.055 | 0.024 | 0.055 | Acetylcholine M1 receptor agonist | |||
| 0.048 | 0.017 | 0.048 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.063 | 0.033 | 0.063 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.084 | 0.054 | 0.084 | Histamine H1 receptor antagonist | |||
| 0.069 | 0.041 | 0.069 | Glutamate (mGluR6) antagonist | |||
| 0.055 | 0.026 | 0.055 | Glutamate (mGluR group I) agonist | |||
| 0.129 | 0.101 | 0.129 | Neuropeptide Y1 antagonist | |||
| 0.058 | 0.031 | 0.058 | Acetylcholine M2 receptor agonist | |||
| 0.072 | 0.046 | 0.072 | Amidase inhibitor | |||
| 0.045 | 0.018 | 0.045 | Farnesoid X receptor agonist | |||
| 0.051 | 0.025 | 0.051 | Purinergic P2Y antagonist | |||
| 0.068 | 0.043 | 0.068 | MDM2 inhibitor | |||
| 0.043 | 0.018 | 0.043 | p53 inhibitor | |||
| 0.062 | 0.039 | 0.062 | Acetylcholine M3 receptor antagonist | |||
| 0.039 | 0.016 | 0.039 | ADAM10 endopeptidase inhibitor | 0.036 0.019 CID_131770057 | ||
| 0.045 | 0.024 | 0.045 | Alpha 1L adrenoreceptor agonist | |||
| 0.062 | 0.041 | 0.062 | Dopamine D4 antagonist | |||
| 0.199 | 0.179 | 0.287 | Antithrombotic | 0.287 0.097 CID_131770057 | CID_131770057 | |
| 0.08 | 0.06 | 0.08 | ALK inhibitor | |||
| 0.061 | 0.043 | 0.061 | Adrenaline uptake inhibitor | |||
| 0.085 | 0.067 | 0.09 | ATPase (Vacuolar H+) inhibitor | 0.09 0.055 CID_131770057 | CID_131770057 | |
| 0.045 | 0.028 | 0.045 | Dopamine D5 antagonist | |||
| 0.038 | 0.022 | 0.038 | Glycine transporter 1 inhibitor | |||
| 0.042 | 0.026 | 0.042 | Factor XIa inhibitor | |||
| 0.045 | 0.029 | 0.045 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.074 | 0.059 | 0.074 | Estrogen receptor alpha antagonist | |||
| 0.142 | 0.128 | 0.142 | Succinate dehydrogenase inhibitor | |||
| 0.059 | 0.045 | 0.059 | Acetylcholine M2 receptor antagonist | |||
| 0.189 | 0.175 | 0.189 | Cholesterol antagonist | |||
| 0.04 | 0.027 | 0.04 | AMPA 4 receptor antagonist | |||
| 0.058 | 0.046 | 0.058 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.037 | 0.027 | 0.037 | G protein-coupled receptor agonist | |||
| 0.052 | 0.042 | 0.052 | CC chemokine 2 receptor antagonist | |||
| 0.037 | 0.027 | 0.037 | NMDA receptor subunit 3A antagonist | |||
| 0.036 | 0.027 | 0.036 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.046 | 0.037 | 0.046 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.04 | 0.033 | 0.04 | Opioid kappa receptor agonist | |||
| 0.048 | 0.042 | 0.048 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.052 | 0.046 | 0.052 | Dopamine uptake inhibitor | |||
| 0.03 | 0.025 | 0.03 | ATP citrate lysase inhibitor | |||
| 0.04 | 0.035 | 0.04 | Nerve growth factor antagonist | |||
| 0.034 | 0.03 | 0.082 | Glutamate (mGluR8) antagonist | 0.082 0.003 CID_131770057 | CID_131770057 | |
| 0.087 | 0.084 | 0.087 | Anabolic | |||
| 0.036 | 0.033 | 0.036 | GABA uptake inhibitor | |||
| 0.053 | 0.051 | 0.053 | Androgen agonist | |||
| 0.096 | 0.097 | 0.157 | Cell adhesion inhibitor | 0.157 0.043 CID_131770057 | CID_131770057 | |
| 0.032 | 0.071 | 0.109 | Protein 50S ribosomal subunit inhibitor | 0.109 0.011 CID_131770057 | CID_131770057 | |
| 0.191 | 0.24 | 0.428 | Antibacterial | 0.428 0.065 CID_131770057 | CID_131770057 | |
| 0.057 | 0.111 | 0.076 | Cell adhesion molecule inhibitor | 0.076 0.059 CID_131770057 | CID_131770057 | |
| 0.118 | 0.177 | 0.282 | Hypolipemic | 0.282 0.055 CID_131770057 | CID_131770057 | |
| 0.171 | 0.246 | 0.262 | Interleukin 2 agonist | 0.262 0.106 CID_131770057 | CID_131770057 | |
| 0.141 | 0.22 | 0.282 | Peptidyltransferase inhibitor | 0.282 0.032 CID_131770057 | CID_131770057 | |
| 0.008 | 0.088 | 0.058 | Squalene synthetase inhibitor | 0.058 0.012 CID_131770057 | CID_131770057 | |
| 0.08 | 0.185 | 0.194 | Anticoagulant | 0.194 0.055 CID_131770057 | CID_131770057 | |
| 0.098 | 0.224 | 0.205 | Platelet antagonist | 0.205 0.098 CID_131770057 | CID_131770057 | |
| 0.06 | 0.199 | 0.104 | Toll-Like receptor 4 antagonist | 0.104 0.063 CID_131770057 | CID_131770057 | |
| 0.083 | 0.228 | 0.135 | Nitric oxide antagonist | 0.135 0.112 CID_131770057 | CID_131770057 | |
| 0.126 | 0.291 | 0.288 | Immunosuppressant | 0.288 0.123 CID_131770057 | CID_131770057 | |
| 0.096 | 0.293 | 0.186 | Hypoglycemic | 0.186 0.127 CID_131770057 | CID_131770057 | |
| 0.032 | 0.233 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.03 CID_131770057 | CID_131770057 | |
| 0.016 | 0.252 | 0.037 | Antibiotic Aminoglycoside-like | 0.037 0.025 CID_131770057 | CID_131770057 | |
| 0.06 | 0.352 | 0.146 | Hepatoprotectant | 0.146 0.114 CID_131770057 | CID_131770057 | |
| 0.026 | 0.49 | 0.24 | Angiogenesis stimulant | 0.24 0.075 CID_131770057 | CID_131770057 | |
| 0.035 | 0.503 | 0.206 | Antioxidant | 0.206 0.11 CID_131770057 | CID_131770057 | |
| 0.073 | 0.552 | 0.351 | Apoptosis agonist | 0.351 0.138 CID_131770057 | CID_131770057 | |
| 0.006 | 0.501 | 0.055 | Selectin antagonist | 0.055 0.054 CID_131770057 | CID_131770057 | |
| 0.026 | 0.532 | 0.18 | DNA polymerase I inhibitor | 0.18 0.035 CID_131770057 | CID_131770057 | |
| 0.023 | 0.537 | 0.172 | Free radical scavenger | 0.172 0.122 CID_131770057 | CID_131770057 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |